Inhibikase Therapeutics IKT Q1 2026 Earnings Narrowing Losses as Pipeline Progress Takes Center Stage MED Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction EOG Resources Q1 2026 Earnings EPS Beats Estimates by 583 Amid Strong Operational Performance OS Q4 2025 Earnings Strong EPS Beat Driven by Operational Efficiency EQBK Q1 2026 Earnings EPS Misses Estimates as Earnings Face Headwinds Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure